Regeneus to attend BioJapan in partnership with AGC

Regeneus featured in the Australian Financial Review on 9 October 2017 (page 35). The story focused on the evolution of stem cell technology and how Japan has become a key market for our cell based regenerative medicine technologies.

This is a good forerunner for BioJapan, Japan's largest biotech and regenerative medicine conference to be held between 11-13 October in Yokohama. Regeneus will be participating in meetings to promote Progenza and Sygenus as well as continuing our discussions with potential licensing and marketing partners.

Read the full article in The Australian Financial Review here.